Retatrutide Raw Powder enhances insulin secretion from pancreatic beta cells while simultaneously reducing inappropriate glucagon release, resulting in improved glucose homeostasis
In contrast, PG-102 achieved a ~450 mg/dL glucose reduction and ~5% HbA1c decrease by 2-months, restoring normoglycemia and maintaining efficacy throughout the 3-month study (Fig
Retatrutide is an investigational triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite and body weight, while tesamorelin is a growth hormone-releasing hormone analogue that stimulates pituitary GH release to reduce visceral fat, primarily in HIV-positive patients with lipodystrophy
They will assess BMI, weight-related conditions, medical history, and contraindications, then recommend which GLP-1 is best for your situation (Wegovy, Zepbound, or Foundayo)
The European Union, for instance, has some of the most stringent aflatoxin standards